Chapare Virus-An Emerging Hemorrhagic Fever Threat: A CBRNE Perspective on Preparedness and Biosecurity Risks

Abstract

Chapare virus (CHAV), an emerging Bolivian arenavirus causing severe hemorrhagic fever, provides a critical case study for rethinking pandemic preparedness in an era of escalating zoonotic threats. With its case-fatality rate exceeding 60% and documented human-to-human transmission, CHAV exemplifies the convergence of natural spillover risks and potential bioterrorism concerns, which warrant its classification alongside U.S. Centers for Disease Control and Prevention (CDC) category A priority pathogens. This study examines how military-derived Chemical, Biological, Radiological, Nuclear, and Explosive (CBRNE) frameworks, including syndromic surveillance networks and advanced biodetection technologies, might transform preparedness for high-consequence arenaviruses. Climate-driven rodent migration in South America exacerbates outbreak risks, and the absence of point-of-care diagnostics and approved therapeutics leaves global health systems vulnerable. We demonstrate how conflict-tested tools, such as portable genomic sequencers and North Atlantic Treaty Organization (NATO)-style biosurveillance protocols, could be repurposed for real-time CHAV monitoring in endemic regions. The analysis identifies urgent gaps in biosecurity policy, particularly regarding rodent-borne viruses, and proposes a dual-pathway strategy to strengthen One Health surveillance while integrating biodefense infrastructure to mitigate both natural outbreaks and intentional releases. This work underscores the imperative to bridge civilian and military preparedness paradigms for emerging zoonoses with pandemic potential.

Keywords

Chapare Virus / CBRNE / Zoonotic Disease / Health Management / Global Security

References

[1] Delgado S, Erickson BR, Agudo R, Blair PJ, Vallejo E, Albariño CG, et al. Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia. PLoS Pathog. 2008; 4(4): e1000047.

[2] Cenciarelli O, Gabbarini V, Pietropaoli S, Malizia A, Tamburrini A, Ludovici GM, et al. Viral bioterrorism: learning the lesson of Ebola virus in West Africa 2013-2015. Virus Res. 2015; 210: 318-326.

[3] Loayza Mafayle R, Morales-Betoulle ME, Romero C, Cossaboom CM, Whitmer S, Alvarez Aguilera CE, et al. Chapare hemorrhagic fever and virus detection in rodents in Bolivia in 2019. N Engl J Med. 2022; 386(24): 2283-2294.

[4] Camp JV, Spruill-Harrell B, Owen RD, Solà-Riera C, Williams EP, Eastwood G, et al. Mixed effects of habitat degradation and resources on hantaviruses in sympatric wild rodent reservoirs within a neotropical forest. Viruses. 2021; 13(1): 85.

[5] Oliveira M, Mason-Buck G, Ballard D, Branicki W, Amorim A. Biowarfare, bioterrorism and biocrime: a historical overview on microbial harmful applications. Forensic Sci Int. 2020; 314: 110366.

[6] Coleman CN, Bader JL, Koerner JF, Hrdina C, Cliffer KD, Hick JL, et al. Chemical, biological, radiological, nuclear, and explosive (CBRNE) science and the CBRNE science medical operations science support expert (CMOSSE). Disaster Med Public Health Prep. 2019; 13(5-6): 995-1010.

[7] Malizia A, Filograna L, Sbordone FP, Ciccarese G, Carbone A, Carreri B, et al. Correction: Malizia et al. Response of a radiology department to the SARS-CoV-2 pandemic: the experience of the hospital “Policlinico Tor Vergata” in Rome. Int. J. Environ. Res. Public Health 2021, 18, 5255. Int J Environ Res Public Health. 2022; 19(8): 4688.

[8] Filip R, Gheorghita Puscaselu R, Anchidin-Norocel L, Dimian M, Savage WK . Global challenges to public health care systems during the COVID-19 pandemic: a review of pandemic measures and problems. J Pers Med. 2022; 12(8): 1295.

[9] Emonet SF, de la Torre JC, Domingo E, Sevilla N. Arenavirus genetic diversity and its biological implications. Infect Genet Evol. 2009; 9(4): 417-429.

[10] Watanabe Y, Bowden TA, Wilson IA, Crispin M. Exploitation of glycosylation in enveloped virus pathobiology. Biochim Biophys Acta Gen Subj. 2019; 1863(10): 1480-1497.

[11] Stott RJ, Strecker T, Foster TL. Distinct molecular mechanisms of host immune response modulation by arenavirus NP and Z proteins. Viruses. 2020; 12(7): 784.

[12] Escalera-Antezana JP, Rodriguez-Villena OJ, Arancibia-Alba AW, Alvarado-Arnez LE, Bonilla-Aldana DK, Rodríguez-Morales AJ. Clinical features of fatal cases of Chapare virus hemorrhagic fever originating from rural La Paz, Bolivia, 2019: a cluster analysis. Travel Med Infect Dis. 2020; 36: 101589.

[13] Cossaboom C, Medina Ramirez A, Romero C, Morales-Betoulle M, de la Vega G, Gutiérrez J, et al. Re-emergence of Chapare hemorrhagic fever in Bolivia, 2019. Int J Infect Dis. 2020; 101: 244-245.

[14] Lindsey BB, Villabona-Arenas CJ, Campbell F, Keeley AJ, Parker MD, Shah DR, et al. Characterising within-hospital SARS-CoV-2 transmission events using epidemiological and viral genomic data across two pandemic waves. Nat Commun. 2022; 13(1): 671.

[15] Furman E, Cressman A, Shin S, Kuznetsov A, Razak F, Verma A, et al. Prediction of personal protective equipment use in hospitals during COVID-19. Health Care Manag Sci. 2021; 24(2): 439-453.

[16] Johnson DM, Fenton KA, Dobias N, Geisbert TW, Cross RW. Natural history of Chapare virus infection in strain 13 guinea pigs. J Infect Dis. 2025; 231(5): e867-e872.

[17] Toledo J, Torrez AP, Terrazas A, Molina Gutiérrez JT, Ramírez AM, Romero C, et al. Public health implications of a new world arenavirus outbreak that occurred in Bolivia, 2019. Travel Med Infect Dis. 2021; 43: 102124.

[18] Ludovici GM, Tassi PA, Iannotti A, Russo C, Quaranta R, Manenti G, et al. Emerging zoonotic threats: HKU5-CoV-2 and the CBRNE approach to pandemic prevention. Infect Dis Immun. 2025.

[19] Koudokpon H, Lègba B, Sintondji K, Kissira I, Kounou A, Guindo I, et al. Empowering public health: building advanced molecular surveillance in resource-limited settings through collaboration and capacity-building. Front Health Serv. 2024; 4: 1289394.

[20] Matsui Y, Chottikamporn J, Ungvanijban S, Seeyo KB, Vitoonpong R, Suwankitwat N, et al. Development of a real-time RT-PCR system applicable for rapid and pen-side diagnosis of foot-and-mouth disease using a portable device, PicoGene^® PCR1100 . J Virol Methods. 2023; 319: 114753.

[21] Li X, Huang S, Sun Z. Technology and equipment development in laser-induced fluorescence-based remote and field detection of biological aerosols. J Biosaf Biosecur. 2019; 1(2): 113-122.

[22] Jain S, Shrivastava-Ranjan P, Flint M, Montgomery JM, Spiropoulou CF, Albariño CG. Development of reverse genetic tools to study Chapare and Machupo viruses. Virology. 2023; 588: 109888.

[23] Kellner MJ, Koob JG, Gootenberg JS, Abudayyeh OO, Zhang F. SHERLOCK: nucleic acid detection with CRISPR nucleases. Nat Protoc. 2019; 14(10): 2986-3012.

[24] van Dongen JE, Segerink LI. Building the future of clinical diagnostics: an analysis of potential benefits and current barriers in CRISPR/Cas diagnostics. ACS Synth Biol. 2025; 14(2): 323-331.

[25] Manenti G, Ludovici GM, D’Amario R, Iannotti A, Russo C, Quaranta R, et al. Implementation and application of a contingency plan in case of an unconventional CBRNe event: a case study in a hospital facility. Defense S&T Tech Bull. 2025; 18: 21-33.

[26] Ludovici GM, Tassi PA, Iannotti A, Russo C, Quaranta R, Manenti G, et al. Bioterrorism and CBRNe threats: the role of Ebola in global security. Ethics Med Public Health. 2025; 33: 101138.

[27] Shurtleff AC, Garza N, Lackemeyer M, Carrion R Jr, Griffiths A, Patterson J, et al. The impact of regulations, safety considerations and physical limitations on research progress at maximum biocontainment. Viruses. 2012; 4(12): 3932-3951.

[28] Graham BS, Sullivan NJ. Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic. Nat Immunol. 2018; 19(1): 20-28.

[29] Xiang C, Zhu Q, Wen J, Xie L, Hao R, Qiu X, et al. Mining and quantitative evaluation of the laboratory biosafety policy in China. PLoS One. 2025; 20(8): e0328923.

[30] Escalera-Antezana JP, Montesinos-Jove RD, Gonzales-Flores CE, Arauco-Gutierrez CN, Aviles-Sarmiento JL, Montenegro-Narvaez CM, et al. Chapare virus hemorrhagic fever (CHHF) in Bolivia, 2020-2025. New Microbes New Infect. 2025; 64: 101569.

[31] Beermann S, Dobler G, Faber M, Frank C, Habedank B, Hagedorn P, et al. Impact of climate change on vector- and rodent-borne infectious diseases. J Health Monit. 2023; 8(Suppl 3): 33-61.